Automation
IT & Software

IT & Software News

View news from other Pharmaceutical sectors:
16-30 of 1781 results
Abzena signs licensing deal for ThioBridge antibody drug conjugate linker technology
Abzena has entered into a licensing agreement with with a San Diego-based biopharmaceutical firm for its novel site-specific ThioBridge antibody drug conjugate (ADC) linker technology.
Automation > IT & Software > News
Pfizer, IBM partner to advance immuno-oncology research
By PBR Staff Writer
Pharmaceutical major Pfizer and technology giant IBM have partnered to accelerate immuno-oncology research.
Automation > IT & Software > News
Menarini-Silicon’s DEPArray technology aids researchers in lung cancer study
Menarini-Silicon Biosystems said its DEPArray single-cell isolation technology played an important role in a study carried out by researchers from The University of Manchester to develop a model for predicting whether small-cell lung cancer patients will be sensitive or resistant to initial chemo­therapy treatment.
Automation > IT & Software > News
Tillotts introduces new technology for colonic targeting of active molecules
Tillotts Pharma has introduced a new advanced enteric coating for solid dosage forms at this year's annual meeting of the American Association of Pharmaceutical Scientists.
Automation > IT & Software > News
PAREXEL launches IDMP-focused software solution for biopharmaceutical firms
PAREXEL International has launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies.
Automation > IT & Software > News
IBM Watson, Broad Institute partner on $50m cancer drug resistance project
By PBR Staff Writer
IBM and the Broad Institute of MIT and Harvard have launched a five-year, $50m research initiative to study why cancers become drug resistant.
Automation > IT & Software > News
DNAtrix licenses Myxoma virus for new immunotherapy platform
DNAtrix, a privately held, clinical stage, biotechnology firm developing virus-driven immunotherapies for cancer, has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.
Automation > IT & Software > News
UK artificial intelligence firm secures rights to several Janssen drug candidates
UK artificial intelligence (AI) firm BenevolentAI has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen Pharmaceutica (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Automation > IT & Software > News
ERS Genomics agrees to license CRISPR/Cas9 to Knudra Transgenics
ERS Genomics and Knudra Transgenics have signed a non-exclusive license agreement on CRISPR-Cas9 genome editing patents for model organisms.
Automation > IT & Software > News
Teva, IBM to develop cognitive technologies for drug repurposing
By PBR Staff Writer
Teva Pharmaceutical Industries and IBM have expanded their worldwide e-health alliance with new projects designed to discover new uses for existing drugs and advance chronic disease management.
Automation > IT & Software > News
IBM makes Watson technology available to US employees fighting cancer
IBM is offering its Watson technology to its US employees to help them identify appropriate cancer treatments and options for clinical trials.
Automation > IT & Software > News
Nexus BioPharma signs deal with TransChem for kinase inhibition technology
Nexus BioPharma has signed an agreement to license TransChem's transition state chemistry technology for kinase inhibition.
Automation > IT & Software > News
Codexis completes final phase in transfer of CodeEvolver technology to Merck
Codexis has completed the second and final phase in the transfer of its CodeEvolver protein engineering platform technology to Merck, known as MSD outside the US and Canada, under a non-exclusive licensing agreement.
Automation > IT & Software > News
Bayer, DelSiTech partner to develop new drug delivery technology for ophthalmology
Bayer and DelSiTech have partnered to develop innovative drug delivery technology for ophthalmology.
Automation > IT & Software > News
AstraZeneca selects LLamasoft as supply chain design technology partner
AstraZeneca has selected LLamasoft’s Supply Chain Guru and Data Guru as tools of choice for supply chain modelling.
Automation > IT & Software > News
16-30 of 1781 results